Skip to main content

Spinal Cord Stimulation Market to Exhibit 8.1% CAGR and Hit USD 4236.2 Million by 2026; Increasing Prevalence of Chronic Spinal Diseases to Enable Growth, says Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Nov. 26, 2020 (GLOBE NEWSWIRE) — According to the report, the global spinal cord stimulation market size was worth USD 2,268.9 Million in 2018. The global market is anticipated to progress at a CAGR of 8.1% and value USD 4,236.2 Million by the end of 2026. The report offers a comprehensive overview on various segments of the global spinal cord stimulation market.  As per the report the global spinal cord stimulation market was dominated by North America in 2018. The North America market was valued at US$ 1,086.7 Mn in 2018.Spinal Cord Stimulation Key Industry Developments:In September 2019, Abbott announced the USFDA approval of PROCLAIM XR, a recharge-free neurostimulation system for treatment of patients with chronic pain.In January 2019, Boston Scientific launched SPECTRA WAVEWRITER spinal cord stimulator system in Europe. The system is used for treatment against chronic pain and debilitating pain.In August 2018, Nevro Corp. received USFDA approval for next-generation SENZA II Spinal Cord Stimulation (SCS) System used to deliver HF10 therapy.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spinal-cord-stimulation-market-100313
Innovation in Spinal Cord Stimulation Therapy to Drive MarketIn the near future, the global spinal cord stimulation market will gain significant impetus from the introduction of MRI conditional spinal cord stimulator. Besides this, reduction in the consumption of opioid medication is fuelling the demand for spinal cord stimulation therapy.Exposure to radiations and side effects associated with spinal cord stimulation therapy are a few factors that may restrain the global spinal cord stimulation market during the forecast period.Regional Analysis:The region is anticipated to remain dominant through the forecast period. Favorable health reimbursement policies available in the region is one of the key factors enabling expansion of the spinal cord stimulation market in North America.Trailing North America, Europe has emerged as the second-leading region in the global market during the forecast period. Rapid technological advancements in the spinal cord stimulation systems is a primary factor expected to fuel the demand for spinal cord stimulation in Europe. Besides this, Asia Pacific is anticipated to report highest CAGR during forecast period.
Click here to get the short-term and long-term impact of COVID-19 on this market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/spinal-cord-stimulation-market-100313
The market in the region is driven by the high demand and rapid adoption of spinal cord stimulation in the region. This is likely to enable growth in the global spinal cord stimulation market.In terms of disease indication, The Failed Back Syndrome segment is estimated to emerge dominant in the global spinal cord stimulation market during the forecast period. The global prevalence of the Failed Back Syndrome is increasing further generating demand for the development of new and effective therapy to treat chronic back pain.Government bodies across the world have introduced several policies encouraging expansion of the healthcare infrastructure. These are facilitating the smooth development of new spinal cord stimulation therapy as well. This is likely to increase the growth rate of the global market.
Quick Buy –  Spinal Cord Stimulation Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100313
Abbot and Boston to Lead the Global MarketAbbott and Boston Scientific Corporation hold a significant share and are together leading the global spinal cord stimulation market. These companies are projected to lead the global market during the forecast period also. The growth witnessed is attributable to successful completion of acquisition of St. Jude Medical Inc. by Abbott.Product launch by Boston Scientific Corporation is also contributing towards the growth. St. Jude Medical Inc., was acquired by Abbot in 2017, which further gave Abbot access to St. Jude Medical’s product portfolio and market share. Strategic collaborations are intended at expanding footprint and product portfolio.Key companies covered in the reportMedtronicAbbottBoston Scientific CorporationStimwave LLCNevro Corp. NuvectraOther players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/spinal-cord-stimulation-market-100313
Segmentation of the Global Spinal Cord Stimulation Market:By Product           •              Implantable Pulse Generatoro              Rechargeableo              Non-rechargeable•              Radiofrequency SystemBy Disease Indication        •              Failed Back Syndrome (FBS)•              Degenerative Disk Disease (DDD)•              Complex Regional Pain Syndrome (CRPS)•              Arachnoiditis•              OthersBy End User         •              Hospital•              Ambulatory Surgical Centers•              Specialty ClinicsBy Geography      •              North America (USA and Canada)•              Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)•              Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)•              Latin America (Brazil, Mexico and Rest of Latin America)•              Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/spinal-cord-stimulation-market-100313
SECONDARY DATA SOURCES THAT WE REFER TO:Annual reports, investor presentation, SEC filings, and press releases of companies operating in the marketStudies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, ClinicsIndustry journals and paid databasesSECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:Medical Devices Market Share and Global Trend By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Wound Management, Diabetes Care, Ophthalmic Devices, Dental & Nephrology), End User (Hospitals & Ambulatory Surgical Centers and Clinics) and Geography Forecast till 2025Peritoneal Dialysis Market Share and Global Trend By Product Type (CAPD, APD), Product (Cyclers, Fluids), End User (Home health care and Hospitals) and Geography Forecast till 2025Veterinary Therapeutics Market Share and Global Trend By Product Type (Drugs, Vaccines), Animal Type (Companion, Livestock), Route of Administration (Oral, Parenteral, Topical), Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) and Geography Forecast till 2025Molecular Diagnostics Market Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025Digital Radiography Market Share and Global Trend By Product Type (Computed Radiography, Direct Digital Radiography), Application (General, Radiography Dentistry, Oncology, Orthopedic) End User (Hospital, Clinics, Diagnostic Centers) and Geography Forecast till 2026
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/spinal-cord-stimulation-market-9101

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.